BioStock: Chairman on Lipum’s progress, vision, and challenges

Ingemar Kihlström has been a member of Lipum’s board since 2021 and currently serves as its Chairman. BioStock reached out to Ingemar to gain insight into Lipum’s opportunities and how he can contribute to a successful transition from phase I to phase II for the drug candidate SOL-116:
– With over 40 years of experience in drug development, including securing financing for similar companies, I have numerous opportunities to contribute to Lipum’s positive development, says Ingemar in an interview with BioStock.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/03/chairman-on-lipums-progress-vision-and-challenges/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se